(3S,4S,6S,9S)-13-[2-(1-Hydroperoxy-1-methylethyl)-4-thiazolyl]-4-hydroxy-12-methyl-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic Acid 5-thiazolylmethyl Ester

(3S,4S,6S,9S)-13-[2-(1-Hydroperoxy-1-methylethyl)-4-thiazolyl]-4-hydroxy-12-methyl-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic Acid 5-thiazolylmethyl Ester Structure
CAS No.
2034136-66-6
Chemical Name:
(3S,4S,6S,9S)-13-[2-(1-Hydroperoxy-1-methylethyl)-4-thiazolyl]-4-hydroxy-12-methyl-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic Acid 5-thiazolylmethyl Ester
Synonyms
RitonavirEP ImpurityG;Ritonavir Hydroperoxide;Ritonavir hydroperoxide F;Ritonavir EP Impurity G (Ritonavir Hydroperoxide);(3S,4S,6S,9S)-13-[2-(1-Hydroperoxy-1-methylethyl)-4-thiazolyl]-4-hydroxy-12-methyl-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic Acid 5-thiazolylmethyl Ester;Thiazol-5-ylmethyl ((2S,3S,5S)-5-((S)-2-(3-((2-(2-hydroperoxypropan-2-yl)thiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-3-hydroxy-1,6-diphenylhexan-2-yl)carbamate (Ritonavir?Impurity);2,7,10,12-Tetraazatridecanoic acid, 13-[2-(1-hydroperoxy-1-methylethyl)-4-thiazolyl]-4-hydroxy-12-methyl-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,4S,6S,9S)-
CBNumber:
CB43954946
Molecular Formula:
C37H48N6O7S2
Molecular Weight:
752.94
MOL File:
2034136-66-6.mol
Modify Date:
2024/4/1 18:08:31

(3S,4S,6S,9S)-13-[2-(1-Hydroperoxy-1-methylethyl)-4-thiazolyl]-4-hydroxy-12-methyl-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic Acid 5-thiazolylmethyl Ester Properties

Boiling point 1005.3±65.0 °C(Predicted)
Density 1.285±0.06 g/cm3(Predicted)
pka 11.47±0.46(Predicted)

(3S,4S,6S,9S)-13-[2-(1-Hydroperoxy-1-methylethyl)-4-thiazolyl]-4-hydroxy-12-methyl-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic Acid 5-thiazolylmethyl Ester Chemical Properties,Uses,Production

Uses

Ritonavir Hydroperoxide is a metabolite of Ritonavir (R535000). Ritonavir is a selective HIV protease inhibitor. It is a COVID19-related research product.

(3S,4S,6S,9S)-13-[2-(1-Hydroperoxy-1-methylethyl)-4-thiazolyl]-4-hydroxy-12-methyl-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic Acid 5-thiazolylmethyl Ester Preparation Products And Raw materials

Raw materials

Preparation Products

(3S,4S,6S,9S)-13-[2-(1-Hydroperoxy-1-methylethyl)-4-thiazolyl]-4-hydroxy-12-methyl-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-tetraazatridecanoic Acid 5-thiazolylmethyl Ester RitonavirEP ImpurityG Ritonavir Hydroperoxide Ritonavir hydroperoxide F 2,7,10,12-Tetraazatridecanoic acid, 13-[2-(1-hydroperoxy-1-methylethyl)-4-thiazolyl]-4-hydroxy-12-methyl-9-(1-methylethyl)-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,4S,6S,9S)- Thiazol-5-ylmethyl ((2S,3S,5S)-5-((S)-2-(3-((2-(2-hydroperoxypropan-2-yl)thiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-3-hydroxy-1,6-diphenylhexan-2-yl)carbamate (Ritonavir?Impurity) Ritonavir EP Impurity G (Ritonavir Hydroperoxide) 2034136-66-6 C37H48N6O7S2